With Democrats now poised to gain control of both chambers of Congress, AMCP published the following deck to outline the impacts of the 2026 midterm election on federal health policy.
Legislative Update: President Trump Signs the One Big Beautiful Bill Act into Law
On July 4, President Donald Trump signed H.R. 1, the One Big Beautiful Bill Act, into law. Flanked by Republican leadership on the White House lawn, the President commemorated passage of the massive budget reconciliation package, which includes an extension of the 2017 Tax Cuts and Jobs Act, additional changes to the tax code excluding portions of tipped, overtime, and Social Security income, additional funding for defense, domestic energy production, and border security, and significant cuts to federal benefit programs including Medicaid, CHIP, and the Supplemental Nutrition Assistance Program (SNAP).
Related
Cell & Gene Therapies (CGT) offer potentially curative treatment to patients with chronic and hereditary conditions but carry high price tags. One proposal to overcome such financing challenges is to create a national risk pool.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services (CMS) for the opportunity to provide comments in response to Medicare Drug Price Negotiation Program: Draft Guidance, Manufacturer Effectuation of the Maximum Fair Price in 2028 (Draft Guidance). CMS issued this draft guidance to describe the processes and requirements for manufacturer effectuation of the maximum fair price (MFP) in 2028 for selected drugs payable under Medicare Part B and/or covered under Medicare Part D.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
